Sarepta Therapeutics
SRPT
SRPT
365 hedge funds and large institutions have $10.9B invested in Sarepta Therapeutics in 2019 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 126 increasing their positions, 116 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
365
Holders Change
-6
Holders Change %
-1.62%
% of All Funds
7.94%
Holding in Top 10
13
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+160%
% of All Funds
0.28%
New
59
Increased
126
Reduced
116
Closed
61
Calls
$550M
Puts
$440M
Net Calls
+$110M
Net Calls Change
+$30.1M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$118M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$115M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$83.1M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$82.4M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$62.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$267M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$68.4M |
| 3 |
HCM
Highline Capital Management
New York
|
-$52M |
| 4 |
BlackRock
New York
|
-$40.2M |
| 5 |
SIG
Senator Investment Group
New York
|
-$37M |
